Media Center

Assets intended for use by media professionals.

For general media inquiries only, please call +1 908-740-5633 or e-mail Media Relations. Members of the media seeking information on a specific topic may also contact the following individuals:

Elizabeth Cooney

Title: Enterprise Social Media
Office Phone: +1 267-305-1158

Pamela Eisele

Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 267-305-3558

Claire Gillespie

Title: Corporate Media Relations
Office Phone: +1 267-305-0932


Additional Contacts


For consumer or patient-related questions, please contact your physician, pharmacist or other health care provider.

To report an adverse experience with a specific Merck product, please call the Merck National Service Center at +1 800-672-6372.

Health Care Professionals:

If you are a physician, pharmacist or other health care provider and have a question(s) or need information about a specific Merck product or service, please call the Merck National Service Center for Health Care Professionals at +1 866-448-7590.

For Stock Holders:

Tel: +1 800-522-9114
Monday-Friday, 7AM – 7 PM CST

For Institutional Investors and Analysts:

Tel: +1 908-423-5881
Monday-Friday, 8:30 AM – 4 PM ET

Merck Corporate



Kenneth C. Frazier




Company Snapshot

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Visit our About Us section.


Everything you need to know about Merck.


Our pipeline is continually evolving and is updated quarterly.


How we govern ourselves as a company is as important as anything else we do.

Join the Conversation

Connect with us on Facebook, Twitter, and LinkedIn to learn more about our corporate initiatives, including those in health and wellness, philanthropy and corporate responsibility.

Scott M. Wright, Social Media +1 267-305-3581

Please read our social media guidelines.

Click to see our latest news in #livercancer: $MRK min 37 sec ago
#CMV infection is widespread and can lead to reactivation and disease in adults undergoing #HSCT #TCTM2019 hours 20 min ago
Did you know that there may be multiple steps of cancer treatment? hours 20 min ago
Click here to read our latest #oncology news in #melanoma: $MRK hours 29 min ago
That's a wrap on #GU19, but our commitment to #InventingForLife continues every single day. See you in June for mor… days 20 hours ago
Though many advances in HIV research have been made since the start of the epidemic in the 1980s, more work is to be done. Learn about our work: b​i​t​.​l​y​/​2​m​y​K​H​m​v
about 5 hours 49 min ago
Learn more about our work in kidney cancer: b​i​t​.​l​y​/​2​I​b​s​y​G​b #GU19
ASCO_KidneyCancer_Most Common_MCK_1920x1080.mp4
about 3 days 2 hours ago
Despite new discoveries in #bladdercancer research, there is still a need for scientific advancement. Watch as our team shares what drives them to address this need. b​i​t​.​l​y​/​2​t​n​1​8​m​m #InventingForLife #GU19
ASCO_Bladder Cancer_2019 Diagnosis_MCK_1920x1080.mp4
about 4 days 3 hours ago